This module uses fundamental data of Global Medical to approximate its Piotroski F score. Global Medical F Score is determined by combining nine binary scores representing 3 distinct fundamental categories of Global Medical REIT. These three categories are profitability, efficiency, and funding. Some research analysts and sophisticated value traders use Piotroski F Score to find opportunities outside of the conventional market and financial statement analysis.They believe that some of the new information about Global Medical financial position does not get reflected in the current market share price suggesting a possibility of arbitrage. Check out Global Medical Altman Z Score, Global Medical Correlation, Global Medical Valuation, as well as analyze Global Medical Alpha and Beta and Global Medical Hype Analysis.
Global
Piotroski F Score
Price To Sales Ratio
Dividend Yield
Ptb Ratio
Days Sales Outstanding
Book Value Per Share
Free Cash Flow Yield
Operating Cash Flow Per Share
Stock Based Compensation To Revenue
Capex To Depreciation
Pb Ratio
Ev To Sales
Free Cash Flow Per Share
Roic
Inventory Turnover
Net Income Per Share
Days Of Inventory On Hand
Payables Turnover
Sales General And Administrative To Revenue
Average Inventory
Capex To Revenue
Cash Per Share
Pocfratio
Interest Coverage
Payout Ratio
Capex To Operating Cash Flow
Pfcf Ratio
Days Payables Outstanding
Income Quality
Roe
Ev To Operating Cash Flow
Pe Ratio
Return On Tangible Assets
Ev To Free Cash Flow
Earnings Yield
Intangibles To Total Assets
Net Debt To E B I T D A
Current Ratio
Tangible Book Value Per Share
Receivables Turnover
Graham Number
Shareholders Equity Per Share
Debt To Equity
Capex Per Share
Graham Net Net
Revenue Per Share
Interest Debt Per Share
Debt To Assets
Enterprise Value Over E B I T D A
Short Term Coverage Ratios
Price Earnings Ratio
Operating Cycle
Price Book Value Ratio
Price Earnings To Growth Ratio
Days Of Payables Outstanding
Dividend Payout Ratio
Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio
Pretax Profit Margin
Ebt Per Ebit
Operating Profit Margin
Effective Tax Rate
Company Equity Multiplier
Long Term Debt To Capitalization
Total Debt To Capitalization
Return On Capital Employed
Debt Equity Ratio
Ebit Per Revenue
Quick Ratio
Dividend Paid And Capex Coverage Ratio
Net Income Per E B T
Cash Ratio
Cash Conversion Cycle
Operating Cash Flow Sales Ratio
Days Of Inventory Outstanding
Days Of Sales Outstanding
Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios
Price To Book Ratio
Fixed Asset Turnover
Capital Expenditure Coverage Ratio
Price Cash Flow Ratio
Enterprise Value Multiple
Debt Ratio
Cash Flow To Debt Ratio
Price Sales Ratio
Return On Assets
Asset Turnover
Net Profit Margin
Gross Profit Margin
Price Fair Value
Return On Equity
Change In Cash
Free Cash Flow
Change In Working Capital
Begin Period Cash Flow
Other Non Cash Items
Capital Expenditures
Total Cash From Operating Activities
Net Income
End Period Cash Flow
Sale Purchase Of Stock
Other Cashflows From Financing Activities
Cash And Cash Equivalents Changes
Total Cash From Financing Activities
Change To Liabilities
Investments
Net Borrowings
Total Cashflows From Investing Activities
Depreciation
Dividends Paid
Cash Flows Other Operating
Change To Account Receivables
Change To Operating Activities
Other Cashflows From Investing Activities
Change To Netincome
Change To Inventory
Change Receivables
Stock Based Compensation
Issuance Of Capital Stock
Total Assets
Other Current Liab
Total Current Liabilities
Total Stockholder Equity
Net Debt
Retained Earnings
Cash
Cash And Short Term Investments
Common Stock Total Equity
Liabilities And Stockholders Equity
Other Current Assets
Other Stockholder Equity
Total Liab
Total Current Assets
Common Stock
Common Stock Shares Outstanding
Net Tangible Assets
Accounts Payable
Retained Earnings Total Equity
Capital Surpluse
Short Long Term Debt Total
Other Liab
Property Plant And Equipment Net
Non Current Assets Total
Non Currrent Assets Other
Other Assets
Long Term Debt
Net Receivables
Short Term Investments
Long Term Debt Total
Non Current Liabilities Total
Property Plant And Equipment Gross
Short Long Term Debt
Accumulated Other Comprehensive Income
Non Current Liabilities Other
Short Term Debt
Property Plant Equipment
Noncontrolling Interest In Consolidated Entity
Good Will
Inventory
Deferred Long Term Liab
Intangible Assets
Capital Lease Obligations
Net Invested Capital
Net Working Capital
Capital Stock
Long Term Investments
Interest Expense
Selling General Administrative
Other Operating Expenses
Operating Income
Ebit
Ebitda
Total Operating Expenses
Income Before Tax
Income Tax Expense
Net Income From Continuing Ops
Net Income Applicable To Common Shares
Depreciation And Amortization
Total Revenue
Gross Profit
Cost Of Revenue
Non Recurring
Total Other Income Expense Net
Research Development
Minority Interest
Net Interest Income
Reconciled Depreciation
Probability Of Bankruptcy
At present, Global Medical's Short and Long Term Debt is projected to increase significantly based on the last few years of reporting. The current year's Net Debt To EBITDA is expected to grow to 5.80, whereas Long Term Debt is forecasted to decline to about 24.6 M. At present, Global Medical's PTB Ratio is projected to decrease significantly based on the last few years of reporting. The current year's Days Sales Outstanding is expected to grow to 82.48, whereas Stock Based Compensation To Revenue is forecasted to decline to 0.03.
At this time, it appears that Global Medical's Piotroski F Score is Strong. Although some professional money managers and academia have recently criticized Piotroski F-Score model, we still consider it an effective method of predicting the state of the financial strength of any organization that is not predisposed to accounting gimmicks and manipulations. Using this score on the criteria to originate an efficient long-term portfolio can help investors filter out the purely speculative stocks or equities playing fundamental games by manipulating their earnings..
The critical factor to consider when applying the Piotroski F Score to Global Medical is to make sure Global is not a subject of accounting manipulations and runs a healthy internal audit department. So, if Global Medical's auditors report directly to the board (not management), the managers will be reluctant to manipulate simply due to the fear of punishment. On the other hand, the auditors will be free to investigate the ledgers properly because they know that the board has their back. Below are the main accounts that are used in the Piotroski F Score model. By analyzing the historical trends of the mains drivers, investors can determine if Global Medical's financial numbers are properly reported.
One of the toughest challenges investors face today is learning how to quickly synthesize historical financial statements and information provided by the company, SEC reporting, and various external parties in order to project the various growth rates. Understanding the correlation between Global Medical's different financial indicators related to revenue, expenses, operating profit, and net earnings helps investors identify and prioritize their investing strategies towards Global Medical in a much-optimized way.
F-Score is one of many stock grading techniques developed by Joseph Piotroski, a professor of accounting at the Stanford University Graduate School of Business. It was published in 2002 under the paper titled Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers. Piotroski F Score is based on binary analysis strategy in which stocks are given one point for passing 9 very simple fundamental tests, and zero point otherwise. According to Mr. Piotroski's analysis, his F-Score binary model can help to predict the performance of low price-to-book stocks.
Book Value Per Share
12.97
At present, Global Medical's Book Value Per Share is projected to slightly grow based on the last few years of reporting.
Global Medical ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Global Medical's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Global Medical's managers, analysts, and investors.
Environmental
Governance
Social
About Global Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Global Medical REIT's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Global Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Global Medical REIT based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Global Medical REIT is a strong investment it is important to analyze Global Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Global Medical's future performance. For an informed investment choice regarding Global Stock, refer to the following important reports:
You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Is Diversified REITs space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Global Medical. If investors know Global will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Global Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.43)
Dividend Share
0.21
Revenue Per Share
2.082
Quarterly Revenue Growth
(0.04)
Return On Assets
0.0171
The market value of Global Medical REIT is measured differently than its book value, which is the value of Global that is recorded on the company's balance sheet. Investors also form their own opinion of Global Medical's value that differs from its market value or its book value, called intrinsic value, which is Global Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Global Medical's market value can be influenced by many factors that don't directly affect Global Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Global Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Global Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Global Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.